跳至主要内容
临床试验/CTRI/2023/11/060024
CTRI/2023/11/060024尚未招募2 期

A clinical Study to determine the effectiveness of Individualized Homoeopathic Medicine in the management of Pityriasis Versicolor

Dr Shruthi Gopi1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2023年11月29日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
35
试验地点
1
主要终点
Changes in signs and symptoms of Pityriasis versicolor using TSSS

研究概览

简要总结

This study is a single arm clinical study to find out the effectiveness of Individualized Homoeopathic Medicine in the management of Pityriasis Versicolor. The primary outcome measures the changes in signs and symptoms of Pityriasis Versicolor using TSSS. The secondary outcome measures the changes in Skindex-16 score. The study duration is 1 year 6 months (6 months for enrollment and 1 year for Intervention and Follow-up)

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients presenting with typical hypopigmented or hyperpigmented macules, scales, pruritis and erythema.
  • 2.Patients confirmed by microscopic KOH test.

排除标准

  • 1.Patients with co-existing dermatological conditions 2.Pregnant and lactating women
  • Patients with advanced systemic illnesses.

结局指标

主要结局

Changes in signs and symptoms of Pityriasis versicolor using TSSS

时间窗: One year

次要结局

  • Changes in Skindex-16 score(One year)

研究者

发起方
Dr Shruthi Gopi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shruthi Gopi

National Homoeopathy Research Institute in Mental Health

研究点 (1)

Loading locations...

相似试验